Development of an oral treatment with the PPAR-γ-acting cannabinoid VCE-003.2 against the inflammation-driven neuronal deterioration in experimental Parkinson’s disease
Journal:
Molecules
ISSN: 1420-3049
Year of publication: 2019
Volume: 24
Issue: 15
Type: Article